CA-50 serum level in patients with prostate cancer
- PMID: 1697710
- DOI: 10.1007/BF00295845
CA-50 serum level in patients with prostate cancer
Abstract
CA-50 antigen is considered to be a generalized carcinoma-associated antigen. CA-50 serum levels were measured by solid phase radioimmunoassay using a specific monoclonal antibody. Sera of 49 patients with prostatic cancer of different clinical stages, 43 patients suffering from BPH, and 28 healthy males were tested. Positive test results were observed in 57.1% of patients with prostate cancer values ranging from 42.9% in stage A to 66.7% in stage D. Increased CA-50 levels were found in 11.6% of patients with BPH.
Similar articles
-
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.Urol Oncol. 2008 Jan-Feb;26(1):47-52. doi: 10.1016/j.urolonc.2007.07.020. Urol Oncol. 2008. PMID: 18190830
-
Differentiation of benign prostatic hyperplasia and prostate cancer employing prostatic-specific antigen density.Eur Urol. 1994;25(4):295-8; discussion 304. doi: 10.1159/000475304. Eur Urol. 1994. PMID: 7519991
-
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.Urology. 1998 May;51(5A Suppl):89-97. doi: 10.1016/s0090-4295(98)00082-x. Urology. 1998. PMID: 9610563
-
[Biomarkers of prostate cancer and potential for using ace produced in prostate gland for diagnosis of prostate cancer and benign prostatic hyperplasia].Urologiia. 2019 Jun;(2):73-81. Urologiia. 2019. PMID: 31162906 Review. Russian.
-
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.J Urol. 1991 May;145(5):907-23. doi: 10.1016/s0022-5347(17)38491-4. J Urol. 1991. PMID: 1707989 Review.
Cited by
-
Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test.Transl Lung Cancer Res. 2024 May 31;13(5):1061-1068. doi: 10.21037/tlcr-24-68. Epub 2024 May 29. Transl Lung Cancer Res. 2024. PMID: 38854948 Free PMC article.
-
Preclinical evaluation of the novel monoclonal antibody H6-11 for prostate cancer imaging.Mol Pharm. 2013 Oct 7;10(10):3655-64. doi: 10.1021/mp400130w. Epub 2013 Sep 3. Mol Pharm. 2013. PMID: 23964702 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical